...
faq Vaginal Laxity (postnatalmenopause support)

When can I resume sex after laser/RF or injectables?

When can I resume sex after laser/RF or injectables? Most women wait until any spotting and soreness settle and the entrance feels comfortable with a generous, compatible lubricant—typically 2–7 days after superficial injectables (e.g., hyaluronic acid boosters, PRP, polynucleotides) and 5–14 days after vaginal laser or radiofrequency. If you’re peri-/post-menopausal with genitourinary syndrome of menopause (GSM), optimising moisturiser and (if acceptable) local oestrogen improves comfort. Educational only. Results vary. Not a cure.

Clinical Context

Who typically resumes sooner? Women having superficial injectables (HA boosters, PRP, polynucleotides) without significant bruising or sting often resume comfortable penetrative sex within 2–7 days using generous lubricant and low-pressure positions. Those with good pelvic floor relaxation cues progress fastest.

Who benefits from a longer pause? After laser/RF, after childbirth, or where GSM causes marked dryness or “paper-cut” fissures, allow up to 5–14 days and prioritise moisturiser and (if acceptable) local oestrogen. Pain-dominant/overactive pelvic floor patterns may need extra down-training before resuming.

Next steps now. Keep a simple diary for 2–4 weeks: sting (0–10), micro-tear/spotting days, ease at first penetration/speculum, and confidence. If comfort isn’t improving, pause, revert to foundations and book review rather than pushing on.

Evidence-Based Approaches

NHS (patient-friendly): Practical guidance on pelvic floor exercises and management of vaginal dryness after menopause underpins conservative care before and after procedures.

NICE menopause guideline (NG23): Recommends vaginal moisturisers/lubricants and considering low-dose local vaginal oestrogen for symptomatic GSM, with shared decision-making about ongoing use. NICE NG23.

NICE interventional guidance (IPG645): Transvaginal laser for urogenital atrophy should be used with special arrangements for consent and audit owing to limited evidence—hence a cautious, outcomes-tracked approach after laser. NICE IPG645.

Cochrane Library: Reviews support pelvic floor muscle training for symptom and quality-of-life gains and highlight heterogeneity/short follow-up for energy devices, guiding realistic post-procedure expectations. Cochrane Library – pelvic floor & GSM.

BNF/MHRA: For medicines/devices used around intimate care, UK sources outline product governance, cautions and reporting routes—useful when planning aftercare and return to activity. BNF · MHRA.